Skip to content

bioRxiv

76 papers in the library · 23 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Psilocybin lengthens hippocampal sharp wave ripples

bioRxiv August 20, 2026 Ilknur Kayikcioglu Bozkir, Ryan Lashin, Tiecheng Liu et al. preprint

Psilocybin is a psychedelic which has been shown to induce neural plasticity through activation of intracellular serotonergic 5-HT2A receptors. It also produces brain-wide changes in structural and functional connectivity and holds promise as a therapeutic compound for treating anxiety and depression. Despite links between psilocybin-induced plasticity, the psychedelic experience, and reduction...

Brain-wide reconfiguration of burst firing by psilocybin reveals 5-HT2A-dependent circuit dynamics

bioRxiv August 19, 2026 D. Momi, Y. Nahas, D. Wyrick et al. preprint

Psilocybin produces rapid and lasting therapeutic effects, yet how 5-HT2A receptor activation reshapes brain-wide circuit dynamics during acute drug administration remains poorly understood. Using simultaneous multi-region Neuropixels recordings of 46,360 single units from 35 mice, together with scalp electroencephalography (EEG), pupillometry, and locomotion monitoring, we provide a...

Multidimensional characterization of the physiological and behavioral effects of TCB-2 in mice

bioRxiv August 6, 2026 Mizuki Yamamoto, Hiroto Inoue, Kazuko Hayashi et al. preprint

Background and Purpose Serotonergic psychedelics affect behavior and physiology, but the relationships among these effects remain poorly understood. In rodents, the head-twitch response is used as a measure of psychedelic-like activity, yet it does not capture changes in physiological state or the performance of learned behaviors. Here, we investigated the acute effects of the 5-HT2A receptor...

Longitudinal Characterization of a Novel Class of Recurrent, Stereotyped Neurophysiological Events in an Advanced Meditator

bioRxiv August 5, 2026 A. Callara, Francesco Bossi, Jampa Soepa et al. preprint

Seven EEG recordings over thirteen months revealed highly stereotyped transitions between distinct brain dynamics in an advanced meditator, providing a rare experimental window onto large-scale brain-state dynamics. We report an intensive longitudinal EEG case study of an experienced Tibetan tantric practitioner recorded across seven different measurement sessions, including concentrative and...

Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure–Response Model

bioRxiv July 23, 2026 W. J. Tyler, E. Sellers, M. McDonnell preprint

Repeated low-dose psilocybin is being developed as a scalable outpatient treatment for mood and anxiety disorders, but chronic exposure raises concern because psilocin binds the cardiac serotonin 5-HT2B receptor, whose sustained agonism causes drug-induced valvular heart disease (VHD). We evaluated this risk using an exposure–response model that incorporates functional efficacy and exposure...

Psilocybin selectively rescues cognitive flexibility impairments caused by aberrant prefrontal error signaling

bioRxiv July 9, 2026 Christine Liu, Ellie M. Ho, Alexander S. Enos et al.

Psychedelic drugs show remarkable potential for treating psychiatric disorders, but the mechanisms underlying their therapeutic effects remain relatively unknown. Here, we demonstrate that psilocybin can powerfully ameliorate deficits in cognitive flexibility, but this effect depends on the specific circuit-level cause of those deficits. Using optogenetic models of cognitive inflexibility in...

Astrocytic μ-δ opioid receptor heterodimers mediate the antidepressant effects of ketamine’s metabolite

bioRxiv June 3, 2026 Shuo Yang, Ling-Jun Wang, Yunxiang Sun et al.

Abstract A deeper understanding of the targets and mechanisms of fast-acting antidepressants, exemplified by ketamine, remains indispensable for better therapeutic strategies and understanding depression. Beyond the canonical neuron-centric NMDAR inhibition hypothesis, brain opioid system and glia-mediated processes are increasingly implicated in ketamine’s antidepressant efficacy, yet their...

High-order brain interactions distinguish wakefulness, anaesthesia, and recovery induced by deep brain stimulation

bioRxiv June 3, 2026 Camilo Espinosa-Curilem, L. Uhrig, Jordie Tasserie et al. preprint

Understanding how consciousness depends on large-scale brain interactions is key for both the neuroscience of consciousness and clinical translation. However, it requires moving beyond classical pairwise descriptions of functional connectivity, which cannot capture the collective dependencies emerging across multiple brain regions. Here, we use multivariate information theory measures to...

(2R,6R)-Hydroxynorketamine elicits rapid antidepressant effects by promoting astrocytic µ-δ opioid receptor heterodimerization

bioRxiv June 3, 2026 Yanxia Liang, Lingjun Wang, Yajie Li et al. preprint

Ketamine produces rapid antidepressant effects but is constrained by psychotomimetic properties and abuse potential. The ketamine metabolite (2R,6R)-hydroxynorketamine (HNK) shows antidepressant-like efficacy without N-methyl-D-aspartate receptor (NMDAR) blockade, yet its upstream targets remain unclear. Here we show that HNK potentiates hippocampal excitatory transmission and reverses...

Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programs

bioRxiv May 29, 2026 Aurora Savino, Carla Liaci, Ilaria Bertani et al.

Summary Psychedelic compounds such as lysergic acid diethylamide (LSD) are increasingly studied for their neuroplastic effects and potential relevance to brain aging and neurodegeneration. However, the molecular mechanisms linking psychedelic-induced plasticity to age-associated cognitive decline remain unclear. Brain aging and dementia are characterized by coordinated transcriptional programs...

Appetite for change: How psilocybin reshapes food reward learning through striatal dopamine function

bioRxiv May 18, 2026 Kyna Conn, Ngok Wong, Serenay Sunnetci et al.

Abstract Psilocybin has emerged as a promising therapeutic agent for psychiatric disorders characterised by cognitive rigidity and disrupted reward processing, including anorexia nervosa. While its pro-cognitive effects have been mechanistically probed almost exclusively through serotonin receptor subtype antagonism, the downstream contributions of dopaminergic systems to these outcomes remain...

Multimodal autonomic arousal tracks dose-dependent affective dynamics during the acute effects of DMT

bioRxiv May 4, 2026 Tomás Ariel D’amelio, Tomás Gil Garbagnoli, Jerónimo Rodríguez Cuello et al.

ABSTRACT Serotonergic psychedelics induce altered states of consciousness characterised by profound changes in emotional experience. Although psychedelics modulate autonomic arousal, sympathetic engagement during their affective effects remains poorly characterised. We recorded cardiac, electrodermal, and respiratory activity in 19 participants following inhalation of 20 or 40 mg of freebase...

Non-traumatic fMRI of identity-state expression and switching in co-conscious DID

bioRxiv April 23, 2026 S. Kajimura, K. Okano, Senkei Ueno et al. preprint

Dissociative identity disorder (DID) remains debated because identity-state phenomena are privately experienced and may be attributed to suggestion, simulation or role enactment. Most neuroimaging studies rely on symptom provocation or traumatic recall, which complicates interpretation and is poorly suited to co-conscious presentations where simultaneous awareness should make state differences...

A joint metabolic–integrative regime of consciousness: evidence from FDG-PET and TMS–EEG

bioRxiv April 22, 2026

Abstract Conscious experience is associated with both sufficient cerebral metabolic support and preserved large-scale neural integration, yet these two constraints have largely been studied in isolation. Whether consciousness requires their joint satisfaction — and whether either alone is sufficient — remains an open question. Here, we test the prediction that conscious states occupy a joint...